Wadhane Jitendra has filed 14 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 109461 shares of Pyxis Oncology, Inc. ($PYXS) on March 24, 2026.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 24, 2026 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | Prin Fin & Acct Officer | A | Common Stock | 109461 | $0.00 | 512,882.0000 | 62,557,386 | 27.13% | 0.17% |
| March 24, 2026 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | Prin Fin & Acct Officer | A | Stock Option (Right to Buy) | 262635 | $0.00 | 262,635.0000 | 62,557,386 | 9999.99% | 0.42% |
| March 31, 2025 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | SVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 263782 | $0.98 | 263,782.0000 | 58,445,765 | 9999.99% | 0.45% |
| Dec. 23, 2024 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | SVP, Chief Accounting Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 60,715,041 | 9999.99% | 0.25% |
| March 26, 2024 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | SVP, Chief Accounting Officer | A | Common Stock | 131484 | $0.00 | 398,421.0000 | 39,904,603 | 49.26% | 0.33% |
| Nov. 15, 2023 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | Chief Accounting Officer | A | Common Stock | 40000 | $0.00 | 266,937.0000 | 0 | 17.63% | 0.00% |
| Sept. 27, 2023 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | Chief Accounting Officer | P | Common Stock | 2500 | $1.87 | 226,937.0000 | 0 | 1.11% | 0.00% |
| Sept. 25, 2023 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | Chief Accounting Officer | P | Common Stock | 5000 | $1.77 | 224,437.0000 | 0 | 2.28% | 0.00% |
| Sept. 22, 2023 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | Chief Accounting Officer | P | Common Stock | 2500 | $1.74 | 219,437.0000 | 0 | 1.15% | 0.00% |
| Sept. 7, 2023 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | Chief Accounting Officer | A | Common Stock | 93896 | $0.00 | 211,937.0000 | 0 | 79.55% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | Chief Accounting Officer | A | Common Stock | 45000 | $0.00 | 88,648.0000 | 0 | 103.10% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | Chief Accounting Officer | D | Stock Option (Right to buy) | 157257 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | Chief Accounting Officer | A | Stock Option (Right to buy) | 157257 | $0.00 | 157,257.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Wadhane Jitendra | Chief Accounting Officer | A | Common Stock | 29393 | $0.00 | 118,041.0000 | 0 | 33.16% | 0.00% |